SAM
IONS icon

Shamrock Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Shamrock Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$6K – 287
2015
Q1 		$6K Sell
100
-100
-50% -$6.79K ﹤0.01% 247
2014
Q4 		$12K Sell
200
-300
-60% -$14.8K ﹤0.01% 188
2014
Q3 		$19K Sell
500
-500
-50% -$17.7K 0.01% 186
2014
Q2 		$34K Hold
1,000
– – 0.01% 185
2014
Q1 		$43K Buy
+1,000
New +$48.5K 0.01% 159

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Shamrock Asset Management's IONS Position: Q2 2015 in Review

Shamrock Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2015, closing a stake of 100 shares — an estimated $6K sold.

Shamrock Asset Management first reported a position in IONS in Q1 2014 and held it in 5 quarters. The position peaked at $43K in Q1 2014. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

  • Shamrock Asset Management reported no remaining Ionis Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Shamrock Asset Management sold 100 Ionis Pharmaceuticals shares in Q2 2015, an estimated $6K.
  • Shamrock Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • Shamrock Asset Management's Ionis Pharmaceuticals position peaked at $43K in Q1 2014.
  • 353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on Shamrock Asset Management's 13F filing for Q2 2015, filed 10 Aug 2015.